SDIX Overview

  • Year Founded
  • 1990

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 5

  • Investments
  • 1

SDIX General Information

Description

Developer and producer antibodies catering to anatomic pathology, biotechnology and pharmaceutical markets. The company's antibody products include critical reagents such as antibodies to Troponin I, AGP, ALB, Apo-A1, and CRP and services include polyclonal development and production in a variety of species as well as large-scale monoclonal antibody production.

Contact Information

Website
www.sdix.com
Formerly Known As
Ensys Environmental Products, Strategic Diagnostics, SDI
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 111 Pencader Drive
  • Newark, DE 19702
  • United States
+1 (800)
Primary Industry
Biotechnology
Parent Company
Origene
Corporate Office
  • 111 Pencader Drive
  • Newark, DE 19702
  • United States
+1 (800)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SDIX Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SDIX‘s full profile, request access.

Request a free trial

SDIX Patents

  • 153

    Total Documents Applications and Grants

  • Total Patents Families

  • 25

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

SDIX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140286936-A1 Anti-human cxcr4 antibodies Active 15-Mar-2013
US-9260527-B2 Anti-human cxcr4 antibodies and methods of making same Inactive 15-Mar-2013
US-20140322236-A1 Anti-human adora2a antibodies Inactive 15-Mar-2013
US-20140271619-A1 Cd20 conformational isomers and methods of using Inactive 12-Mar-2013
US-20120231474-A1 Constructs that allow for detection and quantitation of membrane proteins Inactive 22-Feb-2011 C07K14/723
To view SDIX’s complete patent history, request access »

SDIX Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SDIX‘s full profile, request access.

Request a free trial

SDIX Acquisitions (1)

SDIX’s most recent deal was a Merger/Acquisition with Ensys Environmental Products. The deal was made on 01-Jan-1996.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ensys Environmental Products 01-Jan-1996 Merger/Acquisition Environmental Services (B2B)
To view SDIX’s complete acquisitions history, request access »

SDIX FAQs

  • When was SDIX founded?

    SDIX was founded in 1990.

  • Where is SDIX headquartered?

    SDIX is headquartered in Newark, DE.

  • What industry is SDIX in?

    SDIX’s primary industry is Biotechnology.

  • Is SDIX a private or public company?

    SDIX is a Private company.

  • What is the current valuation of SDIX?

    The current valuation of SDIX is .

  • What is SDIX’s current revenue?

    The current revenue for SDIX is .

  • How much funding has SDIX raised over time?

    SDIX has raised $1.46M.

  • Who are SDIX’s investors?

    Edison Partners, Ensys Environmental Products, First Analysis, Industry Ventures, and North Carolina Enterprise Corporation are 5 of 6 investors who have invested in SDIX.

  • When was SDIX acquired?

    SDIX was acquired on 08-Apr-2013.

  • Who acquired SDIX?

    SDIX was acquired by Origene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »